Repeated antigen inhalation-induced reproducible early and late asthma in guinea pigs.
To develop a model of chronic experimental asthma in guinea pigs, the animal was forced to inhale the mist of a low dose of ovalbumin (OA) adsorbed on fine Al(OH)3 for sensitization once every 4 weeks. The animal was challenged by inhalation with the mist of OA on day 14 after the respective sensitizations. Either the first or the second antigen challenge markedly induced an early asthmatic response (EAR), whereas there was hardly any late asthmatic response (LAR). At the 3rd challenge, LAR also emerged with some severity. These dual responses were consistently observed until the 10th challenge. On the other hand, repeated inhalation/challenge, once every 2 weeks, with OA alone at the same dose tended to lead to the desensitization of the EAR. In addition, LAR was hardly observed throughout the experiments. In both groups, gamma 1 and IgE levels in the serum were elevated by the repetitive antigen inhalations, yet no obvious relationship between these antibody levels and the intensity of either EAR or LAR was recognized. The present results indicate that the asthmatic model with reproducible EAR and LAR developed in this study appears to be very beneficial for the investigation of bronchial asthma and for the assessment of anti-asthma drugs.
Nabe
T
T
Department of Pharmacology, Kyoto Pharmaceutical University, Japan.
Shinoda
N
N
Yamada
M
M
Sekioka
T
T
Saeki
Y
Y
Yamamura
H
H
Kohno
S
S
D000280:Administration, Inhalation; D000403:Airway Resistance / Q000187:drug effects / Q000502:physiology; D000536:Aluminum Hydroxide / Q000008:administration & dosage / Q000276:immunology; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000097:blood / Q000187:drug effects; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D001249:Asthma / Q000276:immunology*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007114:Immunization; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D008297:Male; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D013997:Time Factors
D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D000536:Aluminum Hydroxide; D010047:Ovalbumin